Medly Program
Learn more about the Medly Program and the partnership between Toronto’s UHN and Boehringer Ingelheim Canada to expand it to additional communities.
Search
Managing and treating equine osteoarthritis
Managing and treating equine osteoarthritis
Spark Innovation Challenge
The Type 2 Spark Innovation Challenge encourages innovation, collaboration and change in approaches to addressing T2D in British Columbia. Continue reading.
INSPIRED
Read more about INSPIRED, aimed at expanding a hospital-to-home program to better support people living with chronic obstructive pulmonary disease (COPD).
Vaccine protection against different PRRS virus strains
Vaccine protection against different PRRS virus strains
CONTINUUM
CONTINUUM, a collaborative project, investigates how digital technology can help healthcare professionals manage complex patient cases at home. Keep reading.
EQVALAN® GOLD
EQVALAN® GOLD
New data presented at the ISTH 2015 Congress show Idarucizumab* results in immediate reversal of dabigatran in patients requiring urgent medical procedures or with serious bleeding complications1,2
New data presented at the ISTH 2015 Congress show Idarucizumab* results in immediate reversal of dabigatran in patients requiring urgent medical procedures or with serious bleeding complications1,2